{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Prolapsus viscéral : Questions médicales les plus fréquentes",
"headline": "Prolapsus viscéral : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Prolapsus viscéral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-15",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Prolapsus viscéral"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Prolapsus d'organe pelvien",
"url": "https://questionsmedicales.fr/mesh/D056887",
"about": {
"@type": "MedicalCondition",
"name": "Prolapsus d'organe pelvien",
"code": {
"@type": "MedicalCode",
"code": "D056887",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.300.842.624"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Prolapsus viscéral",
"alternateName": "Visceral Prolapse",
"code": {
"@type": "MedicalCode",
"code": "D014782",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Matthew D Barber",
"url": "https://questionsmedicales.fr/author/Matthew%20D%20Barber",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Hans Peter Dietz",
"url": "https://questionsmedicales.fr/author/Hans%20Peter%20Dietz",
"affiliation": {
"@type": "Organization",
"name": "University of Sydney, Sydney, NSW, Australia."
}
},
{
"@type": "Person",
"name": "Shannon L Wallace",
"url": "https://questionsmedicales.fr/author/Shannon%20L%20Wallace",
"affiliation": {
"@type": "Organization",
"name": "Division of Urogynecology and Pelvic Floor Disorders, Department of Subspecialty Care for Women's Health, Women's Health Institute, Cleveland Clinic Foundation, Cleveland, OH. Electronic address: wallacs8@ccf.org."
}
},
{
"@type": "Person",
"name": "Eric R Sokol",
"url": "https://questionsmedicales.fr/author/Eric%20R%20Sokol",
"affiliation": {
"@type": "Organization",
"name": "Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Bladder Capacity in Women With Overactive Bladder Syndrome: A Cross-sectional Study.",
"datePublished": "2023-06-21",
"url": "https://questionsmedicales.fr/article/37353085",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.urology.2023.06.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Heterogeneity of placebo effects on urinary incontinence in overactive bladder syndrome: A meta-analysis of Japanese placebo-controlled clinical trials.",
"datePublished": "2023-06-15",
"url": "https://questionsmedicales.fr/article/37317904",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/iju.15226"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bladder neck incompetence could be an etiology of overactive bladder syndrome in women with stress urinary incontinence after anti-incontinence surgery: insights from transrectal sonography.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37775546",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00345-023-04639-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "The biopsychosocial impacts of anxiety on overactive bladder in women.",
"datePublished": "2023-02-13",
"url": "https://questionsmedicales.fr/article/36780135",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/nau.25152"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of Vitamin D Supplementation on Overactive Bladder and Urinary Incontinence Symptoms in Older Men: Ancillary Findings From a Randomized Trial.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/36067369",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/JU.0000000000002942"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "États anatomopathologiques",
"item": "https://questionsmedicales.fr/mesh/D020763"
},
{
"@type": "ListItem",
"position": 4,
"name": "Prolapsus",
"item": "https://questionsmedicales.fr/mesh/D011391"
},
{
"@type": "ListItem",
"position": 5,
"name": "Prolapsus d'organe pelvien",
"item": "https://questionsmedicales.fr/mesh/D056887"
},
{
"@type": "ListItem",
"position": 6,
"name": "Prolapsus viscéral",
"item": "https://questionsmedicales.fr/mesh/D014782"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Prolapsus viscéral - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Prolapsus viscéral",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Prolapsus viscéral",
"description": "Comment diagnostique-t-on un prolapsus viscéral ?\nQuels tests sont utilisés pour évaluer un prolapsus ?\nQuels signes cliniques indiquent un prolapsus ?\nLe prolapsus peut-il être confondu avec d'autres conditions ?\nQuelle est l'importance de l'examen physique ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Urinary+Bladder,+Overactive&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Prolapsus viscéral",
"description": "Quels sont les symptômes courants du prolapsus ?\nLe prolapsus peut-il causer des problèmes urinaires ?\nY a-t-il des symptômes digestifs associés ?\nComment le prolapsus affecte-t-il la sexualité ?\nLes symptômes varient-ils selon le type de prolapsus ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Urinary+Bladder,+Overactive&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Prolapsus viscéral",
"description": "Comment prévenir le prolapsus viscéral ?\nLe tabagisme influence-t-il le prolapsus ?\nLes grossesses multiples augmentent-elles le risque ?\nL'âge joue-t-il un rôle dans le prolapsus ?\nLes activités physiques peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Urinary+Bladder,+Overactive&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Prolapsus viscéral",
"description": "Quels traitements sont disponibles pour le prolapsus ?\nQuand la chirurgie est-elle recommandée ?\nLes pessaires sont-ils efficaces ?\nQuels exercices aident à traiter le prolapsus ?\nY a-t-il des traitements médicaux non chirurgicaux ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Urinary+Bladder,+Overactive&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Prolapsus viscéral",
"description": "Quelles complications peuvent survenir avec un prolapsus ?\nLe prolapsus peut-il entraîner des problèmes psychologiques ?\nY a-t-il un risque de récidive après traitement ?\nComment les infections sont-elles liées au prolapsus ?\nLe prolapsus peut-il affecter la fonction intestinale ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Urinary+Bladder,+Overactive&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Prolapsus viscéral",
"description": "Quels sont les principaux facteurs de risque du prolapsus ?\nLe mode de vie influence-t-il le prolapsus ?\nLes antécédents chirurgicaux sont-ils un facteur ?\nLes troubles du collagène sont-ils liés au prolapsus ?\nLe stress physique a-t-il un impact ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Urinary+Bladder,+Overactive&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un prolapsus viscéral ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par examen clinique et imageries comme l'échographie ou l'IRM."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer un prolapsus ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'examen pelvien et des études urodynamiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un prolapsus ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une sensation de pesanteur ou des douleurs pelviennes peuvent indiquer un prolapsus."
}
},
{
"@type": "Question",
"name": "Le prolapsus peut-il être confondu avec d'autres conditions ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec des infections ou des tumeurs pelviennes."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'examen physique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'examen physique est crucial pour évaluer la gravité et le type de prolapsus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du prolapsus ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur pelvienne, incontinence et sensation de masse dans le vagin."
}
},
{
"@type": "Question",
"name": "Le prolapsus peut-il causer des problèmes urinaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des difficultés à uriner ou des fuites urinaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes digestifs associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la constipation ou des difficultés à déféquer peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment le prolapsus affecte-t-il la sexualité ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut causer des douleurs pendant les rapports sexuels et une diminution du désir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de prolapsus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon qu'il s'agit d'un prolapsus vaginal, rectal ou utérin."
}
},
{
"@type": "Question",
"name": "Comment prévenir le prolapsus viscéral ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un poids santé, faire des exercices pelviens et éviter de soulever des charges lourdes."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le prolapsus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut affaiblir les tissus et augmenter le risque de prolapsus."
}
},
{
"@type": "Question",
"name": "Les grossesses multiples augmentent-elles le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les grossesses multiples peuvent affaiblir les muscles pelviens et favoriser le prolapsus."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le prolapsus ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de prolapsus augmente avec l'âge en raison de la perte de tonus musculaire."
}
},
{
"@type": "Question",
"name": "Les activités physiques peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines activités comme le yoga peuvent renforcer le plancher pelvien et prévenir le prolapsus."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le prolapsus ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des exercices de renforcement, des pessaires et la chirurgie."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle recommandée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est recommandée lorsque les symptômes sont sévères et ne répondent pas aux autres traitements."
}
},
{
"@type": "Question",
"name": "Les pessaires sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les pessaires peuvent soutenir les organes et soulager les symptômes sans chirurgie."
}
},
{
"@type": "Question",
"name": "Quels exercices aident à traiter le prolapsus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les exercices de Kegel renforcent les muscles pelviens et peuvent aider à réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements médicaux non chirurgicaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements comme la physiothérapie pelvienne peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un prolapsus ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'incontinence, des infections urinaires et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Le prolapsus peut-il entraîner des problèmes psychologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut causer de l'anxiété, de la dépression et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de récidive après traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le prolapsus peut récidiver même après un traitement chirurgical ou non chirurgical."
}
},
{
"@type": "Question",
"name": "Comment les infections sont-elles liées au prolapsus ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les prolapsus peuvent augmenter le risque d'infections urinaires et vaginales."
}
},
{
"@type": "Question",
"name": "Le prolapsus peut-il affecter la fonction intestinale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des problèmes de constipation et de défécation difficile."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du prolapsus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'accouchement, l'obésité, le vieillissement et les antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le prolapsus ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et le surpoids augmentent le risque de prolapsus."
}
},
{
"@type": "Question",
"name": "Les antécédents chirurgicaux sont-ils un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interventions chirurgicales pelviennes antérieures peuvent augmenter le risque de prolapsus."
}
},
{
"@type": "Question",
"name": "Les troubles du collagène sont-ils liés au prolapsus ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du collagène peuvent affaiblir les tissus de soutien et favoriser le prolapsus."
}
},
{
"@type": "Question",
"name": "Le stress physique a-t-il un impact ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des efforts répétés ou un stress physique excessif peuvent contribuer au prolapsus."
}
}
]
}
]
}
To evaluate bladder capacity in women with idiopathic overactive bladder syndrome (OAB) through bladder diary, cystomanometry, and uroflowmetry and assess the concordance of the different measures of ...
An observational cross-sectional multicentric study was conducted, including female patients diagnosed with idiopathic OAB. All participants underwent a urodynamic study and completed a 3-day bladder ...
Bladder capacity measures were diminished in this population, except for VVmax. Poor correlation was found between the different bladder capacity variables (ICC and weighted Kappa index <0.4). Twenty-...
MCC and average VV are reduced in OAB patients. MCC does not correlate well with functional bladder volumes determined by voiding diary in the OAB population....
The effect sizes, changes over time, and heterogeneity of placebo effects on frequency of urination for voiding disorders in Japanese clinical trials have been published. This study evaluated the char...
A meta-analysis of Japanese placebo-controlled clinical trials was conducted to determine placebo effects on the daily frequency of overall (n = 16) and urge (n = 11) incontinence and identify factors...
The between-study heterogeneity variance of placebo effects for overall and urge incontinence at 8 weeks was estimated as I...
This meta-analysis confirmed the characterization of placebo effects on overall and urge incontinence, which demonstrates heterogeneity between trials. The impact of population, follow-up period, and ...
To investigate the prevalence of bladder neck incompetence (BNI) and the anatomic differences between different types of urinary incontinence (UI) and overactive bladder (OAB) by transrectal sonograph...
A retrospective analysis was conducted on a total of 184 patients with SUI, MUI, urge UI (UUI), or OAB dry who underwent transrectal ultrasound between 2017 and 2022. The presence of BNI and urethral ...
Among the patients, 91%, 84%, 76%, and 71% exhibited BNI in MUI, SUI, UUI, OAB dry group, respectively. Significantly higher rate of patients with BNI were found in MUI than in OAB dry group. Patients...
A higher BNI rate was observed in the MUI group. A significantly higher BNI rate was observed in women with OAB symptoms after anti-incontinence surgery. Patients with MUI had improved OAB symptoms if...
Links between emotional state and the bladder have long been recognized, as psychological comorbidity is a common feature of overactive bladder (OAB). However, how psychological factors might contribu...
In a sample of 120 adult women with OAB, we compared those with at least mild anxiety (PROMIS Anxiety score ≥55) to those with lower anxiety. Analyses focused on patient-reported questionnaires assess...
Thirty-six (30%) women had at least mild anxiety. While there were no group differences for urinary symptom severity, more anxious women reported worse OAB-specific quality of life, greater psychologi...
Women with OAB and at least mild anxiety symptoms reported greater psychosocial burdens (i.e., psychological stress, stress reactivity, OAB-specific QOL) and somatic symptom severity and demonstrated ...
Our goal was to evaluate vitamin D supplementation for preventing or treating overactive bladder and urinary incontinence in men....
Ancillary study of men aged ≥55 years in VITAL (VITamin D and OmegA-3 TriaL). Randomized treatments included: vitamin D...
Among the 11,486 men who provided data at year 2 and 10,474 at year 5, mean age was 68 years at year 2, with 23% racial/ethnic minorities. In primary analyses, vitamin D supplementation compared to pl...
Overall, vitamin D supplementation did not improve overactive bladder or urinary incontinence compared to placebo. However, specific use of vitamin D in men with lower 25-hydroxyvitamin D levels had i...
The eCoin (Valencia Technologies Corporation, Valencia, CA) is a battery-powered, nickel-sized and shaped neuromodulation device for the treatment of overactive bladder, and it is implanted in the low...
This was a prospective, single-arm, open-label study, including 23 participants with refractory urgency urinary incontinence (UUI) who were previously participants in the eCoin clinical feasibility tr...
Participants of the study were considered responders if they reported a ≥ 50% reduction from baseline in episodes of UUI on a 3-day voiding diary. At 12 weeks of treatment, 74% (95% confidence interva...
The reimplantation of eCoin was both safe and effective in treating UUI associated with overactive bladder syndrome. The demonstrated significant reduction or resolution of symptoms with no serious sa...
The objective of this study was to investigate the presence of nonbladder sensory abnormalities in participants with overactive bladder syndrome (OAB)....
Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) study participants with OAB symptoms and controls were recruited from 6 U.S. tertiary referral centers. Quantitative sensory testing...
A total of 297 participants were analyzed (191 OAB, 106 controls; 76% white, 51% male). OAB cases were older than controls (57.4 vs 52.2 years, p=0.015). No significant differences in experimental thu...
As a group, no significant differences between OAB cases and controls were observed in experimental nonbladder pain or auditory sensitivity during QST. Associations between QST outcomes and clinical p...
Anticholinergic medications to treat overactive bladder (OAB) have been associated with increased risk of cognitive decline, whereas β3-adrenoceptor agonists (hereafter, β3-agonists) have comparable e...
To evaluate whether patient race, ethnicity, and sociodemographic characteristics are associated with receipt of anticholinergic vs β3-agonist OAB medications....
This study is a cross-sectional analysis of the 2019 Medical Expenditure Panel Survey, a representative sample of US households. Participants included individuals with a filled OAB medication prescrip...
A prescription for medication to treat OAB....
The primary outcomes were receipt of a β3-agonist or an anticholinergic OAB medication....
An estimated 2 971 449 individuals (mean age, 66.4 years; 95% CI, 64.8-68.2 years) filled prescriptions for OAB medications in 2019; 2 185 214 (73.5%; 95% CI, 62.6%-84.5%) identified as female, 2 326 ...
In this cross-sectional study of a representative sample of US households, non-Hispanic Black individuals were significantly less likely than non-Hispanic White individuals to have filled a β3-agonist...
It is unknown whether gabapentin modulates the therapeutic effect of anticholinergics (AC) in patients with overactive bladder. We hypothesized that pre-existing gabapentin use would improve response ...
Female patients treated with AC between 2010-2018 were identified. Data were collected on gabapentin use, indication, dose and duration of use as well as demographic and clinical characteristics. Pati...
Seven hundred fifty-six subjects met all criteria; 16.5% (n = 125) were on combination therapy. Those taking gabapentin were more likely to have chronic (49.6% vs. 22.5%, p < 0.001) or neuropathic pai...
Pre-existing gabapentin use does not seem to influence response to AC in patients with overactive bladder....
There is growing interest in how social determinants of health may explain relationships between social conditions and health. Overactive bladder is common in the United States, posing a significant p...
A community-based sample of adults was recruited electronically to complete questionnaires on clinical and demographic information, urinary symptoms and unmet social needs. Multivariable logistic regr...
The sample of 3,617 participants had a mean±SD age of 47.9±17.3 years. The majority of participants identified as White, non-Hispanic (83.5%), and female (77.6%). A total of 1,391 patients (38.5%) wer...
Multiple unmet social needs were associated with overactive bladder, which may have implications for the overall management of overactive bladder patients. It is important for providers to consider th...